7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Adverse drug-related effects among electronic dance music party attendees

        , , , ,

      International Journal of Drug Policy

      Elsevier BV

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Drug use is prevalent among electronic dance music (EDM) party attendees, but research is needed to determine the extent of adverse drug-related outcomes in this population in order to better inform prevention and harm reduction efforts. 1,029 adults were surveyed entering EDM parties in New York City in 2018. Those reporting past-year use of a drug were asked if they experienced a harmful or very unpleasant effect after use in which they were concerned about their immediate safety. They were also asked about co-use of other drugs and whether they sought help. We estimate that a third (33.5%) of EDM attendees has experienced a drug-related adverse effect in the past year. Two-thirds (67.8%) of adverse effects involved use of alcohol. Relative to use, adverse effects most commonly resulted from use of opioids (e.g., prescription opioid misuse, 41.1%) or alcohol (33.9%). Concomitant use of other drugs was common, particularly among users of cocaine (55.7%), LSD (55.7%), ketamine (56.5%), LSD (41.2%), and ecstasy/MDMA/Molly (47.7%). Adverse effects resulting from synthetic cathinone (“bath salt”) use were most likely to result in a hospital visit (57.1%), followed by opioids (e.g., prescription opioids: 14.3%). Adverse effects from drug use are common among those in the EDM scene and polydrug use appears to be a common risk factor. More research is needed, however, to determine the extent of event-specific adverse outcomes. Results can inform prevention and harm reduction efforts in this population.

          Related collections

          Author and article information

          Journal
          International Journal of Drug Policy
          International Journal of Drug Policy
          Elsevier BV
          09553959
          November 2019
          November 2019
          : 73
          : 81-87
          Article
          10.1016/j.drugpo.2019.07.005
          6899195
          31349134
          © 2019

          Comments

          Comment on this article